Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Autoantibody PositiveNon-diabetic Relatives at Risk for Type 1 DiabetesHigh RiskImpaired Glucose Tolerancetype 1 diabetespre-diabeticat risk for type 1 diabetesglucose intolerancerelatives of people with type 1 diabetesDiabetes MellitusDiabetes Mellitus, Type 1Teplizumab
Lead Scientist at UCSF
- Stephen Gitelman
I am involved in a variety of different translational and clinical research projects, most related to diabetes. A number of the on-going studies are attempts to alter the course of autoimmune-mediated type 1 diabetes, often via immunomodulation, in order to preserve endogenous beta cell function. Some of the recent and on-going projects are described below.